These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11424717)

  • 21. Leukemia occurring after treatment of small cell lung cancer.
    Vogelzang NJ; Arthur D; Kennedy BJ
    Cancer Treat Rep; 1982 Aug; 66(8):1683-4. PubMed ID: 6286123
    [No Abstract]   [Full Text] [Related]  

  • 22. Randomized phase II trial of OK-432 in patients with malignant pleural effusion due to non-small cell lung cancer.
    Kasahara K; Shibata K; Shintani H; Iwasa K; Sone T; Kimura H; Nobata K; Hirose T; Yoshimi Y; Katayama N; Ishiura Y; Kita T; Nishi K; Nakatsumi Y; Ryoma Y; Fujimura M; Nakao S
    Anticancer Res; 2006; 26(2B):1495-9. PubMed ID: 16619563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progressive overlap syndrome due to small cell lung cancer as a paraneoplastic syndrome.
    Yano S; Kobayashi K; Kato K
    Respiration; 2007; 74(5):588-91. PubMed ID: 16534179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer.
    Badzio A; Kurowski K; Karnicka-Mlodkowska H; Jassem J
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):183-8. PubMed ID: 15200999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vivo sensitivity test of anti-cancer drugs against malignant lung tumor xeno-graft].
    Kitano M
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1175-80. PubMed ID: 6088834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Small-cell lung tumor associated with erythroleukemia reaction in peripheral blood and syndrome of disseminated intravascular coagulation].
    Hrycek A; Badowski R; Szwed Z
    Wiad Lek; 1993 Aug; 46(15-16):619-22. PubMed ID: 7975590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Eosinophilia caused by solid malignancy].
    Niamut SM; de Vries PA; van Putten JW; de Jong RS
    Ned Tijdschr Geneeskd; 2004 Sep; 148(38):1883-6. PubMed ID: 15497785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of malignant rheumatoid arthritis complicated by secondary amyloidosis and membranous nephropathy].
    Nakanishi K; Iwahashi C; Handa Y; Hara N; Hamada K; Nagai Y; Kawamura S; Nakamura K
    Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):607-11. PubMed ID: 9893461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Membranoproliferative glomerulonephritis associated with small cell lung carcinoma.
    Usalan C; Emri S
    Int Urol Nephrol; 1998; 30(2):209-13. PubMed ID: 9607894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy for lung cancer: the state of the art in 2009.
    Higgins MJ; Ettinger DS
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1365-78. PubMed ID: 19827996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Waging war on lung cancer.
    Brown E
    FDA Consum; 1999; 33(3):7-8, 10-1. PubMed ID: 10443183
    [No Abstract]   [Full Text] [Related]  

  • 32. Pleural effusion in lung cancer.
    Sahn SA
    Clin Chest Med; 1993 Mar; 14(1):189-200. PubMed ID: 8384963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgA nephropathy and small cell lung carcinoma.
    Yacoub G; Kosseifi SG; Shah LS; Byrd RP; Roy TM
    Tenn Med; 2008 Mar; 101(3):35-7, 40. PubMed ID: 18459646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting lethal minimal residual disease in small cell lung cancer.
    Patel JD; Krug LM; Azzoli CG; Gomez J; Kris MG; Miller VA
    Semin Oncol; 2003 Feb; 30(1):79-85. PubMed ID: 12635092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Small-cell lung cancer and rapidly fatal nephritic syndrome].
    Yangui I; Msaad S; Smaoui M; Makni S; Kammoun K; Khébir A; Boudawara T; Ayoub A
    Rev Pneumol Clin; 2007 Oct; 63(5 Pt 1):331-4. PubMed ID: 18166938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Normalization of obstructive lung insufficiency in patients under cytostatic treatment for small cell anaplastic lung carcinoma].
    Osterlind K; Dombernowsky P; Schroll M; Rose C
    Ugeskr Laeger; 1980 Oct; 142(41):2688-90. PubMed ID: 6255652
    [No Abstract]   [Full Text] [Related]  

  • 38. [SIADH as only paraneoplastic cause of the small cell lung cancer].
    Lokaj P; Krivan L
    Vnitr Lek; 2008 Mar; 54(3):273-5. PubMed ID: 18522296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
    Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenetic concepts of membranous glomerulopathy (MGN).
    Kerjaschki D
    J Nephrol; 2000; 13 Suppl 3():S96-100. PubMed ID: 11132040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.